Disentangling the origin of chemical differences using GHOST
Morphine presentation
1.
2. Opioid drugs, typified by morphine, produce
their pharmacological actions, including
analgesia, by acting on receptors located on
neuronal cell membranes.
3. Morphine (1804):
Named after the Greek God, Morpheus (God of dreams)
Good for treating dull, constant pain rather than sharp, periodic pain.
Side effects:
-Excitation, Euphoria
-Nausea, Pupil constriction
-Constipation,
-Tolerance and Dependence,
-Depression of breathing.
4. Why it gives feelings of Euphoria and causes addiction?
There are different types of Opioid Receptors,
Its action depends on the type of receptor morphine binds to…
7. Now, Let’s see together the effect of masking or removing functional groups on
activity…
1- The Phenol Moiety:
Masking the phenol group resulted in decreased activity, thus it is crucial for
activity.
R=H Morphine
R=Me Codeine
Codeine 20% active (injected
peripherally)
0.1% active (injected into brain)
NMe
O
RO
HO
H
H
8. 2- The 6-alcohol:
•Activity increases due to reduced polarity
•Compounds cross the blood brain barrier more easily
•6-OH is not important for binding
NMe
O
HO
HO
NMe
O
HO
O
NMe
O
HO
9. R=Ac 6-Acetylmorphine
Increased activity (4x)
•Acetyl masks a polar alcohol group making it easier to cross BBB
•Phenol group is free and molecule can bind immediately
•Dependence is very high
•6-Acetylmorphine is banned in many countries
NMe
O
HO
RO
H
H
10. 3- The Double Bond at 7,8:
Dihydromorphine
Increased activity
The alkene group is not important to binding.
NMe
O
HO
HO
H
H
11. 4- The 3o
Amine:
No activity
Nitrogen is essential to binding.
CHMe
O
HO
HO
H
H
12. NR= NH Normorphine
Reduced activity (25%)
NR= N+Me2
No activity
•Normorphine is more polar and crosses the BBB slowly
•Note: R affects whether the analogue is an agonist (axial and reaching to agonist site) or an
antagonist (equatorial and reaching to antagonist site), rigidification could be applied to
stabilize such conformations.
•Optimum distance between 3
o
amine and phenyl ring is essential for activity.
NR
O
HO
HO
H
H
14. Morphine analogsavailable as drugs:
1- Codeine (1832):
How it’s related: Methyl ether of morphine.
Activity: 20% that of morphine.
Treats: Moderate pain, Coughs, diarrhea.
15. 2- Heroin (1874):
How it’s related: 3,6-diacetyl ester of morphine.
Activity: 2x that of morphine as it is easier to cross BBB.
Treats: Pain in terminally ill patients.
Side effects: Euphoria, addiction, tolerance.
16. 5- Methadone(1937):
How its related: Rings B,C,D,E opened.
Activity: Less than Morphine.
Used to: Treat addiction.
Advantages: Can be given orally, Less side effects.
17. 3- Levorphanol (1948):
How it’s related: Ether bridge removed.
Activity: 5x that of morphine.
Advantage: It can be taken orally, Lasts longer, Easier to synthesize.
Side effects: High toxicity, comparable dependence.
18. 4- Fentanyl (1960):
How it’s related: Rings B,C,D removed.
Activity: 100x that of morphine.
Advantages: Cross BBB efficiently, Really easy to make, Rapid onset, short
duration, Can be administered any route (IV, oral, transdermal, buccal).
Used for: Anesthesia and Chronic pain management
Side effects: Sudden respiratory depression, More addictive than heroin, Less
euphoria, more sedation.
19. 8- Dipipanone (1970):
How it’s related: Rings B,C,D opened.
Activity: Similar to morphine.
Used for: Patients allergic to morphine.
Side effects: Sudden respiratory depression, risk of abuse.
20. 6- Sufentanil (1974):
How it’s related: Rings B,C,D removed.
Activity: 500x that of morphine
Advantages: Strongest Pain killer available for humans.
Used for: in surgery and post-operative pain management for patients that are
heavily Opioid tolerant because of long term opiate use.
Side effects: Sudden respiratory depression, anaphylaxis in rare cases.
21. 7-Tapentadol (2008):
How it’s related: Rings B,C,D removed.
Activity: Weak μ agonist and inhibit the reuptake of norepinephrine (similar to
Tramadol).
Advantages: Less side effects.
Used for: Indicated for controlling the pain of diabetic neuropathy.
Side effects: Dependence and addiction.
22. References:
1-The Annals of Pharmacotherapy: Overview of Oral Modified-Release Opioid Products for the Management of
Chronic Pain, by: Celene M. Amabile, Bill J. Bowman.
2- Bioorganic & Medicinal Chemistry: Design, synthesis, and structure–activity relationship of novel opioid κ-
agonists, by: Koji Kawai et al.
3- Indian J Anaesth.: Sufentanil Vs Fentanyl for Fast-Track Cardiac Anaesthesia, by: C M Deshpande et al.
4- Expert Opinion on Pharmacotherapy: Mechanistic and functional differentiation of tapentadol and tramadol, by:
Robert B Raffa, Helmut Buschmann.